Details for New Drug Application (NDA): 220865
The generic ingredient in TAPENTADOL HYDROCHLORIDE is tapentadol hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the tapentadol hydrochloride profile page.
Summary for 220865
| Tradename: | TAPENTADOL HYDROCHLORIDE |
| Applicant: | Msn |
| Ingredient: | tapentadol hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 220865
| Mechanism of Action | Opioid Agonists |
Suppliers and Packaging for NDA: 220865
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TAPENTADOL HYDROCHLORIDE | tapentadol hydrochloride | TABLET;ORAL | 220865 | ANDA | Novadoz Pharmaceuticals LLC | 72205-369 | 72205-369-91 | 100 TABLET, FILM COATED in 1 BOTTLE (72205-369-91) |
| TAPENTADOL HYDROCHLORIDE | tapentadol hydrochloride | TABLET;ORAL | 220865 | ANDA | Novadoz Pharmaceuticals LLC | 72205-370 | 72205-370-91 | 100 TABLET, FILM COATED in 1 BOTTLE (72205-370-91) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
| Approval Date: | Sep 3, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | Sep 3, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
| Approval Date: | Sep 3, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
